Acquisition Completed

Amgen acquisition of Dark Blue Therapeutics

US$840m equity value

Announced 6 Jan 2026

Advisers

Target
Dark Blue Therapeutics
Acquirer
Amgen
Target based in
United Kingdom
Buyer based in
United States
Completed
6 Jan 2026
Sector
Biotech
Tags
Biotech, Oncology, Drug Development

In the league tables

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.